Ingevity NGVT Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $1.2B-9.5% | $1.33B+0.6% | $1.32B-20.9% | $1.67B+19.9% | ||
| $729.7M-16.5% | $873.4M— | —— | $1.1B+25.0% | ||
| $471.5M+3.8% | $454.4M+2.1% | $445M-21.9% | $570.1M+11.2% | ||
| 39.3%+5.0pp | 34.2%+0.5pp | 33.7%-0.5pp | 34.2%-2.7pp | ||
| $29.2M+9.0% | $26.8M+5.5% | $25.4M-16.2% | $30.3M+15.2% | ||
| $171.8M+4.2% | $164.8M+1.9% | $161.8M-18.6% | $198.8M+10.9% | ||
| $109.3M— | $0— | $0— | —— | ||
| -$25.1M+60.0% | -$62.7M-487% | $16.2M+853% | $1.7M— | ||
| $78.3M-19.9% | $97.8M+4.8% | $93.3M+51.0% | $61.8M+19.5% | ||
| $5.2M-32.5% | $7.7M+22.2% | $6.3M-16.0% | $7.5M+87.5% | ||
| -$148.3M— | —— | —— | $269.6M+65.6% | ||
| —— | —— | —— | $58M+29.8% | ||
| -$167.1M+62.6% | -$446.9M-8,176% | -$5.4M-103% | $211.6M+79.2% | ||
| -13.9%+19.7pp | -33.7%-33.2pp | -0.4%-13.1pp | 12.7%+4.2pp | ||
| -$4.15— | —— | $2.90— | —— | ||
| -$0.46— | —— | -$3.05— | —— | ||
| -$4.62+62.4% | -$12.29-7,129% | -$0.17-103% | $5.51+88.1% | ||
| -$4.60+62.6% | -$12.30-7,588% | -$0.16-103% | $5.54+87.2% | ||
| —— | —— | —— | —— | ||
| -$4.15— | —— | $2.9— | —— | ||
| -$4.15— | —— | $2.88— | —— | ||
| -$0.46— | —— | -$3.03— | —— | ||
| $109.3M— | $0— | $0— | —— | ||
| -$150.3M— | —— | $105.8M— | —— | ||
| -$25.1M+60.0% | -$62.7M-487% | $16.2M+853% | $1.7M— | ||
| $27.5M-69.1% | $89M+66.7% | $53.4M+287% | $13.8M— | ||
| $1.2B-9.5% | $1.33B+0.6% | $1.32B-20.9% | $1.67B+19.9% | ||
| -$70M— | —— | —— | $331.4M+54.5% | ||
| $36.4M— | —— | —— | $440.2M+35.7% | ||
| $36.4M— | —— | —— | $440.2M+35.7% | ||
| 3%— | —— | —— | 26.4%+3.1pp | ||
| -$70M— | —— | —— | $331.4M+54.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Ingevity's income statement data come from?
- Every line is extracted from Ingevity's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.